Viewing Study NCT00681850


Ignite Creation Date: 2025-12-24 @ 5:04 PM
Ignite Modification Date: 2025-12-26 @ 10:14 PM
Study NCT ID: NCT00681850
Status: COMPLETED
Last Update Posted: 2020-01-22
First Post: 2008-05-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: OPtimal Type 2 dIabetes Management Including Benchmarking and Standard trEatment.
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module